Kraig Biocraft Laboratories, Inc. Commissions New Production Rearing Center
KBLB
Published on 05/11/2026 at 12:36 pm EDT
Kraig Biocraft Laboratories, Inc. announced the successful commissioning of another recombinant spider silk production rearing center. The new facility is already in operation as part of the Company's aggressive and strategic production expansion program. The newly commissioned facility was brought online in less than 30 days.
It is now supporting the Company's April/May production cycle. The rapid deployment of this facility reflects the Company's growing expertise in scaling production. Kraig Labs has standardized facility layouts, production workflows, staffing procedures, and operational systems. This approach allows the Company to quickly duplicate recombinant spider silk production capacity.
The Company's multi-facility production strategy is designed to increase both capacity and resiliency. By operating across multiple production centers, Kraig Labs creates operational redundancy and reduces concentration risk. The strategy also gives the Company greater flexibility as it rapidly scales toward commercial production targets.
According to the Company, the newest facility follows the same production architecture and operational framework already proven in prior facilities. This standardization allows new production centers to come online faster and more efficiently with each expansion cycle. The commissioning of this facility follows a series of recent production milestones.
Earlier this year, the Company launched an aggressive scale-up initiative aimed at rapidly increasing recombinant spider silk output. Since then, Kraig Labs has expanded production capacity, deployed new production hybrids, increased cocoon processing throughput, and achieved consecutive record-setting production runs. Kraig Labs expects to continue deploying additional production capacity throughout 2026.